Multivariate analysis adjusted by significant risk factor

Risk Factor

Patients with aGVHD and risk factor, n

OR

p-value

Peripheral blood

23

11.4

0.001

Infection 3 months prior to allogeneic transplant

8

4.5

0.03

CMV infection in the recipient

4

4.68

0.03

PB > BM

20

16.3

0.001

Cell Dose > 8.3 × 10⁶/kg

3

4.6

0.03